City of Hope Has Targeted Cancer Care With New AI
The healthcare provider aims to reduce wait times and improve outcomes by using AI to streamline cancer treatment workflows.
Updated on Oct. 9, 2026 in Cancer
Live Poll
Do you trust healthcare institutions to prioritize patient access as they adopt new technologies?
City of Hope is implementing artificial intelligence across its five specialized cancer hospitals to accelerate drug discovery and improve diagnostic imaging. The expansion effort, which now reaches patients in four states, aims to make cancer a manageable condition for more people.
Why it matters
By deploying AI in clinical workflows, the organization intends to reduce patient wait times and address outcome disparities often linked to a patient's zip code. This approach seeks to provide broader access to expert-level care while bolstering public trust in personalized treatment models.
The institution manages five specialized cancer hospitals serving 86 million Americans within driving distance, supported by a research model that cycles findings from bench to bedside. While medical knowledge doubled every 73 days by 2020, the clinical impact of these AI tools remains preliminary.
The players
City of Hope
A network of five specialized cancer hospitals and research centers focused on advancing personalized medicine and patient care access.
Robert Stone
The Chief Executive Officer of City of Hope who leads the institutional adoption of AI strategies to transform oncology service delivery.
Access Hope
A subsidiary organization founded by City of Hope that connects nearly 10 million workers to specialized cancer care models.
The details
City of Hope integrates AI to optimize diagnostic imaging, cybersecurity, and clinical workflow management to streamline the patient journey. By moving research directly from the laboratory bench to the bedside and back again, the organization creates a feedback loop that adapts treatments to individual patient needs. This strategy focuses on reducing operational bottlenecks to ensure patients receive timely interventions regardless of their geographic location.
Timeline
Medical knowledge doubled every 73 days by 2020.
Robert Stone discussed these strategies on October 9, 2026.
Cancer is envisioned to become a manageable condition within the next two decades.
Health Landscape
The expansion of AI-driven oncology services in the United States mirrors objectives found in the Cancer Care Equity Act in California by aiming to reduce geographic disparities in patient outcomes. This strategy follows a pattern set by the legislation in seeking to standardize access to care.
If you are managing a cancer diagnosis, ask your care team about the diagnostic technologies available at your facility and whether they utilize AI to expedite results. Discussing your specific access to specialized care models with your physician can help identify options tailored to your location.
The takeaway
The move toward AI-integrated oncology highlights a shift toward faster, data-driven treatment cycles that prioritize reducing patient wait times. Patients should monitor for improvements in local service accessibility and continue to discuss the role of personalized medicine in their treatment plans.
Further reading
For more on the latest research and standard of care, see Cancer.
Source note: This article includes information reported by Los Angeles Times.
Live Poll
Do you trust healthcare institutions to prioritize patient access as they adopt new technologies?
